Carotegrast
CAS: 401904-75-4
Ref. 3D-BRA90475
| 5mg | Nachfragen | ||
| 10mg | Nachfragen | ||
| 25mg | Nachfragen | ||
| 50mg | Nachfragen | ||
| 100mg | Nachfragen |
Produktinformation
Carotegrast is a drug that has been approved for the treatment of HIV infection. It is a prodrug that is hydrolyzed in vivo to carotegravir and piperazine. Carotegravir inhibits the HIV-1 protease, blocking the processing of viral proteins, which prevents new virus particles from being released. The activity of carotegravir has been shown in vitro and in clinical trials to be similar to that of other protease inhibitors such as saquinavir and ritonavir. Piperazine, a piperazine compound, has antiviral properties and may help to prevent HIV-1 replication by inhibiting reverse transcriptase activity. Carotegrast is effective against a wide range of HIV-1 subtypes and strains, including multidrug resistant isolates. This drug also has an excellent safety profile with no significant adverse events reported during clinical trials.
Chemische Eigenschaften
Technische Anfrage zu: 3D-BRA90475 Carotegrast
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.
